Cuprina Holdings Cayman Limited Receivables Turnover Ratio (CUPR), from the fourth quarter 2025 to the fourth quarter 2024 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Cuprina Holdings cayman Limited  (NASDAQ: CUPR)
 

Cuprina Holdings Cayman Limited Accounts Receivables Turnover Ratio from the fourth quarter 2025 to the fourth quarter 2024

Quarterly Results, Trends, Rankings, Statistics


Cuprina Holdings Cayman Limited's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2025 to a ratio of 1.2, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the fourth quarter 2025. Average receivable collection period, for the Cuprina Holdings Cayman Limited in Dec 31 2025 quarter, has decreased to 304 days, compared to 341 days, in the 0 quarter.

If we take a look into Healthcare sector 635 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2025 from 3885 to 4555.

What is Receivable Turnover Ratio?
What is Cuprina Holdings Cayman Limited Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CUPR Receivables Turnover Ratio (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Receivable Change -5.69 % -26.99 % 150.28 % -26.99 % 44.16 %
Y / Y Revenue Change 9.2 % - - - -
Receivable Turnover Ratio (TTM) 1.2 1.07 1.03 1.31 1.25
CUPR's Total Ranking # 4555 # 3885 # # #
Accounts Receivable average collection period days 304 340 354 279 292
Seq. Receivable Change 269.77 % -70.83 % 242.8 % -74.49 % 186.25 %
Seq. Revenue Change - - - - -


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 194
Healthcare Sector # 636
Overall Market # 4555

Receivable Turnover Ratio Statistics
High Average Low
0.01 0.01 0.01
(Dec 31 2025)  





CUPR Company Profile • Back to CUPR Efficiency Comparisons • Compare CUPR Receivables Turnover Ratio to its Competitors

Financial Statements
Cuprina Holdings Cayman Limited's Accounts Receivable $ 0 Millions Visit CUPR's Balance sheet
Cuprina Holdings Cayman Limited's Sales TTM $ 0 Millions Visit CUPR's Income Statement
Sources of CUPR's Revenues Visit CUPR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CUPR's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CUPR's Growth Rates CUPR's Roa CUPR's Inventory Turnover Ratio CUPR's Dividend Comparisons
CUPR's Profitability Ratios CUPR's Roi CUPR's Asset Turnover Ratio CUPR's Dividend Growth
CUPR's Valuation Ratios CUPR's Roe CUPR's Financial Strength Ratios CUPR's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Receivable at quarter ending Dec 31 2025
Aytu Biopharma Inc  1.88 $ 61.870  Millions$ 32.840  Millions
Heron Therapeutics Inc   1.88 $ 154.557  Millions$ 82.325  Millions
Nyxoah Sa  1.84 $ 11.325  Millions$ 6.166  Millions
Coherus Oncology inc   1.82 $ 42.172  Millions$ 23.164  Millions
Ocular Therapeutix Inc   1.78 $ 51.951  Millions$ 29.263  Millions
Cardiff Oncology Inc   1.74 $ 0.593  Millions$ 0.342  Millions
Amarin Corp Plcuk  1.59 $ 213.646  Millions$ 134.765  Millions
Cardio Diagnostics Holdings Inc   1.42 $ 0.015  Millions$ 0.010  Millions
Sinovac Biotech Ltd  1.35 $ 385.981  Millions$ 286.344  Millions
Dianthus Therapeutics Inc   1.34 $ 2.036  Millions$ 1.523  Millions
Regen Biopharma Inc   1.28 $ 0.237  Millions$ 0.184  Millions
Hcw Biologics Inc   1.26 $ 0.054  Millions$ 0.043  Millions
Assertio Holdings inc   1.22 $ 118.713  Millions$ 97.200  Millions
Surrozen Inc   1.18 $ 3.477  Millions$ 2.941  Millions
Onemednet Corporation  1.17 $ 0.461  Millions$ 0.394  Millions
Rafael Holdings Inc  1.14 $ 1.029  Millions$ 0.900  Millions
Cuprina Holdings cayman Limited  0.74 $ 0.039  Millions$ 0.052  Millions
Innate Pharma Sa  0.70 $ 10.181  Millions$ 14.553  Millions
Meihua International Medical Technologies Co Ltd  0.69 $ 61.792  Millions$ 90.011  Millions
Cardiff Lexington Corporation  0.58 $ 11.536  Millions$ 19.867  Millions
Baird Medical Investment Holdings Limited  0.46 $ 21.884  Millions$ 47.285  Millions
Prophase Labs Inc   0.38 $ 4.339  Millions$ 11.278  Millions

Date modified: 2026-09-08T15:11:40+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.